Blue Crest Capital Management LTD Lannett CO Inc Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $96,736 - $174,576	-28,203 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $133,964 - $408,943	28,203 New	28,203 $134,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $206,735 - $271,242	-15,544 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.7 - $24.95 $228,496 - $387,822	15,544 New	15,544 $249,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.